140 likes | 255 Views
This initiative by the University of Toronto aims to transform pharmaceutical development through innovative cheminformatics solutions. By automating reaction planning and streamlining the drug development process, the project reduces scale-up time from two years to just two months, ensures extended patent protection, and uncovers new reaction pathways. With a strong team and strategic partnerships in R&D and academia, the initiative seeks to enhance efficiency in the pharmaceutical industry and provide essential training and support for stakeholders.
E N D
Revolutionizing pharmaceutical development by Lilien Cheminformatics University of Toronto, December 2009 SynPlan@gmail.com
University of Toronto, December 2009 Chemists use pen & paper to generate reaction plans for target molecule. ...over 100 million chemical substances and sequences! 2
The Solution University of Toronto, December 2009 • Automate Planning • Reduce scale-up time from 2 yrs to 2 months • Extended patent protection • Discover new reaction pathways. 3
Business Model Canvas Infrastructure Customer Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 University of Toronto, December 2009
Business Model Canvas Infrastructure Customer Partner Network Key Activities R&D Academia Education & Training Reaction DB Key Resources Publishing Companies Experts in chemistry & technology. Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009
Business Model Canvas Infrastructure Customer Partner Network Key Activities Pharmaceutical companies R&D Academia Distribution Channel Education & Training Reaction DB Networking within Universities Website with cd/dvds of products Key Resources Publishing Companies Experts in chemistry & technology. Reaction DB updates Training, Support Finance Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009
Business Model Canvas Infrastructure Customer Partner Network Key Activities Pharmaceutical companies R&D Academia Distribution Channel Education & Training Reaction DB Networking within Universities Website with cd/dvds of products Key Resources Publishing Companies Experts in chemistry & technology. Reaction DB updates Training, Support Finance Cost Structure Revenue Streams Maintenance R&D Yearly Licensing Model Support Staff Marketing Assignment 5 | Dejana Bajic, Brian Keng, Amanda Manarin, Maria Mirza & Peter Park | Nov 16, 2009 4 University of Toronto, December 2009
Competition Efficiency ARChem Theresa LHASA SynChem Completeness University of Toronto, December 2009
The Magic • Expertise • Over 10 years of research • Partners • Close relations industry contacts • Opportunity • Increasing cost • Decreased drug approval University of Toronto, December 2009
The Team • Peter Park, CEO • Brian Keng, CFO • Dejana Bajic, VP Sales and Marketing • Maryah Safi, VP Product Development • Amanda Manarin, Sales and Finance University of Toronto, December 2009
University of Toronto, December 2009 TotalOperatingCosts TotalRevenue Net Earnings 8
How you can help • Invest $1.2 million: • Alpha release of product • Covers cash flow for first year • Establish contacts with phamas University of Toronto, December 2009